Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 8/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL932721 | 0.82 | PARP1 (0.39) | IDO1PARP1ALDH1A1TSHR | |
| SCHEMBL15298776 | 0.82 | AGXT (0.48) | IDO1PARP1ALDH1A1MAOBRAB9A | |
| SCHEMBL9889127 | 0.82 | TAAR1 (0.45) | IDO1PARP1ALDH1A1CYP3A4 | |
| SCHEMBL6753184 | 0.80 | PARP1 (0.39) | IDO1PARP1 | |
| SCHEMBL109956 | 0.80 | CYP3A4 (0.47) | IDO1CYP3A4APP | |
| SCHEMBL18824993 | 0.80 | PARP1 (0.41) | IDO1PARP1TSHR | |
| SCHEMBL481295 | 0.80 | IDO1 (0.47) | IDO1PARP1ALDH1A1MAOBAPP | |
| SCHEMBL1315107 | 0.79 | TSHR (0.46) | IDO1PARP1TDP1ALDH1A1TSHR | |
| SCHEMBL145704 | 0.78 | MAOB (0.43) | IDO1PARP1CYP3A4MAOBMAOA | |
| SCHEMBL1491341 | 0.77 | TSHR (0.44) | IDO1TDP1GFERALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116589395-B | Carbazole methylphenyl ether derivative, preparation method and application thereof | 浙江工业大学 | 2025-03-04 | — | — | CN | disclosed |
| US-9278905-B2 | Production method for compound comprising amino group and/or hydroxyl group | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2016-03-08 | — | — | US | disclosed |
| US-20150105559-A1 | PRODUCTION METHOD FOR COMPOUND COMPRISING AMINO GROUP AND/OR HYDROXYL GROUP | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2015-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150105559-A1 | PRODUCTION METHOD FOR COMPOUND COMPRISING AMINO GROUP AND/OR HYDROXYL GROUP | CA7, DAO, CA4 | IDO1 510/4885PARP1 4712/4885TDP1 4705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.